✦ LIBER ✦

CV3 COST-EFFECTIVENESS OF RIVAROXABAN VERSUS ENOXAPARIN FOR PREVENTION OF VENOUS THROMBOEMBOLISM (VTE) AFTER TOTAL KNEE REPLACEMENT (TKR) IN CHINA

✍ Scribed by Chen, XB; Wang, CY; Eggington, S; Zhu, M

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PCV19 COST-EFFECTIVENESS OF RIVAROXABAN

✍ Chen, XB; Eggington, S; Wang, CY; Zhu, M 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 62 KB

PCV49 COST-EFFECTIVENESS ANALYSIS OF RIV

✍ P. Vorobyev; L. Krasnova; O. Borisenko; D. Lukyantseva; E. Bashlakova 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 55 KB

PCV43 COST-EFFECTIVENESS ANALYSIS OF RIV

✍ P. Vorobyev; L. Krasnova; O. Borisenko; D. Lukyantseva; E. Bashlakova 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 57 KB

PCV11 COST-EFFECTIVENESS OF RIVAROXABAN

✍ Pereira, R; Duran, A; Lindner, L; Toro, W; Arango, CH 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 65 KB

A systematic review of rivaroxaban versu

✍ Song Turun; Liao Banghua; Yin Yuan; Li Zhenhui; Nie Ying; Chen Jin 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 985 KB

PCV38 COST-EFFECTIVENESS OF RIVAROXABAN

✍ J Kim; R Pollock; S Jung; A Diamantopoulos; M Lees 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 128 KB